Profile data is unavailable for this security.
About the company
Everest Medicines Ltd is a biopharmaceutical company primarily engaged in the discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines. The Company has built a product pipeline across renal, anti-infective, and autoimmune diseases. The Company’s products portfolio includes Nefecon (TARPEYO) using in the renal therapeutic area, XERAVA (eravacycline) using in the treatment of infections caused by susceptible gram-positive, gram-negative and anaerobic pathogens including those multidrug resistant isolates and other products. The Company conducts its business in the domestic and overseas markets.
- Revenue in HKD (TTM)461.61m
- Net income in HKD-1.16bn
- Incorporated2017
- Employees520.00
- LocationEverest Medicines Ltd16/F., CITIC Pacific Plaza,1168 West Nanjing Road, JingAn DistrictSHANGHAI 200041ChinaCHN
- Websitehttps://www.everestmedicines.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beijing Luzhu Biotechnology Co Ltd | 0.00 | -308.74m | 4.30bn | 148.00 | -- | 4.16 | -- | -- | -1.52 | -1.52 | 0.00 | 5.14 | 0.00 | -- | -- | 0.00 | -23.80 | -- | -25.44 | -- | -- | -- | -- | -- | 5.91 | -- | 0.0296 | -- | -- | -- | 65.62 | -- | -- | -- |
Cutia Therapeutics | 219.31m | -578.29m | 4.44bn | 360.00 | -- | 3.39 | -- | 20.25 | -1.90 | -1.90 | 0.7205 | 4.31 | 0.1206 | 2.31 | 6.93 | 735,949.90 | -31.81 | -- | -35.82 | -- | 50.33 | -- | -263.68 | -- | 4.82 | -- | 0.1818 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
Shandong Boan Biotechnology Co Ltd | 793.90m | 68.17m | 4.90bn | 813.00 | 68.44 | 3.04 | 33.90 | 6.18 | 0.1337 | 0.1337 | 1.56 | 3.01 | 0.3069 | 1.10 | 2.60 | 976,501.30 | 2.63 | -- | 3.43 | -- | 74.10 | -- | 8.59 | -- | 1.03 | 4.01 | 0.3224 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
Sihuan Pharmaceutical Holdings Group Ltd | 1.94bn | -41.69m | 5.03bn | 2.65k | -- | 1.03 | -- | 2.60 | -0.0045 | -0.0045 | 0.2085 | 0.5232 | 0.1506 | 0.9641 | 1.98 | 673,759.10 | -1.77 | -6.85 | -2.68 | -9.10 | 65.91 | 75.81 | -11.78 | -36.23 | 1.52 | -1.39 | 0.181 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
AIM Vaccine Co Ltd | 1.31bn | -1.31bn | 5.16bn | 1.56k | -- | 1.34 | -- | 3.95 | -1.08 | -1.08 | 1.08 | 3.19 | 0.1462 | 0.6325 | 1.10 | 804,189.20 | -22.69 | -- | -37.16 | -- | 72.34 | -- | -155.22 | -- | 0.6836 | -6.61 | 0.3437 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
Consun Pharmaceutical Group Ltd | 3.02bn | 922.45m | 5.23bn | 3.18k | 5.41 | 1.28 | 5.18 | 1.73 | 1.14 | 1.14 | 3.75 | 4.83 | 0.5209 | 2.00 | 11.77 | 966,028.20 | 15.97 | 12.04 | 23.24 | 19.25 | 74.22 | 74.55 | 30.66 | 24.89 | 2.80 | -- | 0.1144 | 40.84 | 10.71 | 7.03 | 14.88 | 11.01 | -22.93 | 18.43 |
Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 811.75m | 122.05m | 5.68bn | 948.00 | 15.45 | 0.7139 | -- | 6.99 | 0.1158 | 0.1158 | 0.7632 | 2.51 | 0.2504 | 1.26 | 1.35 | 856,278.10 | 3.75 | 7.03 | 4.66 | 9.05 | 91.25 | 92.17 | 14.97 | 17.26 | 3.78 | -- | 0.0052 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | -- |
Tong Ren Tang Technologies Co Ltd | 7.58bn | 717.74m | 6.30bn | 4.01k | 8.78 | 0.8052 | 4.39 | 0.8308 | 0.5604 | 0.5604 | 5.92 | 6.11 | 0.5026 | 0.9881 | 5.22 | 1,849,466.00 | 7.42 | 7.68 | 11.69 | 12.32 | 40.97 | 43.50 | 14.76 | 16.11 | 2.30 | -- | 0.1968 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | -0.0089 |
Beijing Tong Ren Tang Chinese Medicine | 1.38bn | 494.14m | 6.35bn | 779.00 | 12.86 | 1.67 | 10.28 | 4.62 | 0.5903 | 0.5903 | 1.64 | 4.55 | 0.3284 | 0.3554 | 3.62 | 1,725,133.00 | 12.72 | 16.71 | 14.09 | 18.75 | 72.06 | 69.88 | 38.72 | 40.72 | 9.55 | -- | 0.0327 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
China Shineway Pharmaceutical Group Ltd | 4.64bn | 1.22bn | 6.62bn | 3.44k | 4.96 | 0.8177 | 4.74 | 1.43 | 1.61 | 1.61 | 6.14 | 9.78 | 0.4476 | 1.28 | 5.26 | 1,349,568.00 | 11.76 | 8.03 | 15.47 | 9.77 | 75.21 | 74.55 | 26.27 | 17.87 | 3.14 | -- | 0.0457 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
Yichang Hec Changjiang Pharmactcl Co Ltd | 6.11bn | 1.82bn | 7.29bn | 4.89k | 4.01 | 0.7633 | 3.46 | 1.19 | 2.07 | 2.07 | 6.94 | 10.86 | 0.4272 | 2.50 | 3.57 | 1,323,156.00 | 11.69 | 8.03 | 17.27 | 11.81 | 78.90 | 79.97 | 27.37 | 20.80 | 1.93 | 25.51 | 0.2126 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
Cansino Biologics Inc | 672.22m | -955.84m | 7.96bn | 1.49k | -- | 0.9408 | -- | 11.84 | -3.87 | -3.87 | 2.72 | 22.59 | 0.0676 | 1.28 | 0.8385 | 449,948.20 | -10.15 | -4.27 | -13.73 | -5.60 | 14.38 | -- | -150.19 | -27.72 | 2.19 | -- | 0.3028 | -- | -66.52 | 213.94 | -63.04 | -- | 30.60 | -- |
Everest Medicines Ltd | 461.61m | -1.16bn | 8.10bn | 520.00 | -- | 1.64 | -- | 17.54 | -3.61 | -3.61 | 1.43 | 15.16 | 0.0756 | 5.23 | 3.22 | 1,068,552.00 | -19.03 | -30.52 | -20.21 | -33.14 | 75.74 | -- | -251.64 | -5,745.25 | 4.62 | -- | 0.1119 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
SSY Group Ltd | 6.47bn | 1.37bn | 11.30bn | 5.80k | 8.30 | 1.56 | 6.18 | 1.75 | 0.4593 | 0.4593 | 2.18 | 2.44 | 0.5418 | 2.75 | 3.07 | 1,155,141.00 | 11.54 | 10.51 | 14.88 | 14.03 | 54.39 | 58.72 | 21.30 | 18.62 | 2.06 | 28.65 | 0.323 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
Luye Pharma Group Ltd | 6.96bn | 849.73m | 11.36bn | 5.27k | 13.37 | 0.7912 | 6.64 | 1.63 | 0.2259 | 0.2259 | 1.85 | 3.82 | 0.236 | 2.44 | 2.84 | 1,321,269.00 | 3.11 | 2.80 | 5.47 | 4.45 | 68.73 | 70.53 | 13.18 | 10.39 | 1.20 | 2.96 | 0.4016 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
Data as of Sep 20 2024. Currency figures normalised to Everest Medicines Ltd's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
Janchor Partners Ltd.as of 30 Sep 2023 | 15.88m | 4.88% |
The Vanguard Group, Inc.as of 04 Sep 2024 | 3.85m | 1.18% |
BlackRock Advisors LLCas of 30 Jun 2024 | 3.11m | 0.96% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 3.05m | 0.94% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 2.32m | 0.71% |
BlackRock Fund Advisorsas of 05 Sep 2024 | 2.18m | 0.67% |
Dimensional Fund Advisors LPas of 05 Sep 2024 | 1.75m | 0.54% |
Zhong Geng Fund Management Co. , Ltd.as of 31 Dec 2023 | 1.12m | 0.34% |
Wellington Management Co. LLPas of 27 Feb 2023 | 678.30k | 0.21% |
SSgA Funds Management, Inc.as of 05 Sep 2024 | 452.00k | 0.14% |
More ▼
Data from 13 Nov 2023 - 19 Sep 2024Source: FactSet Research Systems Inc.